PofoliaShared via Pofolia

Science· 2026Q1

Loss of the tumor suppressor p53 generates a signaling gradient that drives epithelial clonal expansion

Qiwen Gan, Wei Li, Rachel Lex, Zhe Ying et al.

Short summary

Loss of the tumor suppressor p53 in mouse epidermis generates a spatial gradient of Wnt signaling activity, which drives sustained clonal expansion of mutant cells.

AI-generated from the title and abstract; the full text is not read.

Key points

  • p53 loss in mouse epidermis leads to sustained clonal expansion.
  • p53 directly targets Sfrp1, Lrp1, and Usp22, which regulate progenitor renewal.
  • p53 loss generates a radial gradient of Wnt activity across mutant clones.
  • A Wnt activity gradient, not uniform elevation, drives clonal expansion.

AI-generated from the title and abstract; the full text is not read.

Abstract

Although tumor protein p53 ( TP53 ) mutations are among the most common lesions in epithelial cancers, how p53 loss drives unrestrained clonal expansion remains unclear. Working with mouse epidermis, we found that p53 suppresses clonal expansion by limiting progenitor self-renewal. Integrating chromatin immunoprecipitation sequencing, transcriptional analyses, and genetic screens, we identified a p53-dependent network controlling progenitor renewal and differentiation, in which secreted frizzled-related protein 1 ( Sfrp1 ), low-density lipoprotein receptor–related protein 1 ( Lrp1 ), and ubiquitin-specific peptidase 22 ( Usp22 ) were direct targets of p53 and the most genetically upstream components. Their suppression after p53 loss generated a radial gradient of Wnt activity across mutant clones. Genetic manipulation showed that a Wnt activity gradient, rather than uniform elevation, was associated with sustained clonal expansion. These findings identify spatial organization as a determinant of clonal behavior and a mechanism by which TP53 inactivation drives tissue colonization.

The authors' abstract, as published at the source. Science, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Oncology

OncologyMedicine